Delivra Health Brands Inc.

TSXV:DHB Stock Report

Market Cap: CA$10.9m

Delivra Health Brands Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Gord Davey

Chief executive officer

CA$590.2k

Total compensation

CEO salary percentage73.71%
CEO tenure5yrs
CEO ownership4.5%
Management average tenure5.6yrs
Board average tenure7.1yrs

Recent management updates

Recent updates

Is Delivra Health Brands (CVE:DHB) A Risky Investment?

Sep 05
Is Delivra Health Brands (CVE:DHB) A Risky Investment?

Health Check: How Prudently Does Delivra Health Brands (CVE:DHB) Use Debt?

May 08
Health Check: How Prudently Does Delivra Health Brands (CVE:DHB) Use Debt?
User avatar

CA Pharmaceuticals Firm Will Boost Competitive Edge Through R&D And Market Expansion

Expansion into new geographies and enhanced customer loyalty aims to boost revenue and diversify revenue streams for growth.

Delivra Health Brands Inc.'s (CVE:DHB) Business Is Trailing The Market But Its Shares Aren't

Jan 23
Delivra Health Brands Inc.'s (CVE:DHB) Business Is Trailing The Market But Its Shares Aren't

Health Check: How Prudently Does Harvest One Cannabis (CVE:HVT) Use Debt?

May 29
Health Check: How Prudently Does Harvest One Cannabis (CVE:HVT) Use Debt?

Did The Underlying Business Drive Harvest One Cannabis' (CVE:HVT) Lovely 345% Share Price Gain?

Feb 11
Did The Underlying Business Drive Harvest One Cannabis' (CVE:HVT) Lovely 345% Share Price Gain?

CEO Compensation Analysis

How has Gord Davey's remuneration changed compared to Delivra Health Brands's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2025n/an/a

-CA$131k

Dec 31 2024n/an/a

CA$9k

Sep 30 2024n/an/a

CA$172k

Jun 30 2024CA$590kCA$435k

CA$876k

Mar 31 2024n/an/a

-CA$708k

Dec 31 2023n/an/a

-CA$1m

Sep 30 2023n/an/a

CA$423k

Jun 30 2023CA$563kCA$408k

-CA$184k

Mar 31 2023n/an/a

-CA$2m

Dec 31 2022n/an/a

-CA$3m

Sep 30 2022n/an/a

-CA$6m

Jun 30 2022CA$401kCA$395k

-CA$7m

Mar 31 2022n/an/a

-CA$12m

Dec 31 2021n/an/a

-CA$12m

Sep 30 2021n/an/a

-CA$21m

Jun 30 2021CA$299kCA$250k

-CA$23m

Mar 31 2021n/an/a

-CA$24m

Dec 31 2020n/an/a

-CA$54m

Sep 30 2020n/an/a

-CA$55m

Jun 30 2020CA$325kCA$220k

-CA$57m

Compensation vs Market: Gord's total compensation ($USD422.97K) is above average for companies of similar size in the Canadian market ($USD159.30K).

Compensation vs Earnings: Gord's compensation has increased whilst the company is unprofitable.

CEO

Gord Davey

5yrs
Tenure
CA$590,160
Compensation

Mr. Gord Davey has been Chief Executive Officer at Delivra Health Brands Inc. (formerly known as Harvest One Cannabis Inc.) since February 8, 2021. Mr. Davey served as Interim Chief Executive Officer at De...

Leadership Team

NamePositionTenureCompensationOwnership
Frank Holler
Independent Executive Chairman7.1yrsCA$120.00k3.43%
CA$ 375.0k
Gord Davey
President5yrsCA$590.16k4.52%
CA$ 494.1k
Jack Tasse
CFO & Corporate Secretary4.8yrsCA$347.91k0.42%
CA$ 46.4k
Ann Gallery
Senior Vice President of Corporate Communications7.1yrsno datano data
Jonathan Hartshorn
President & CEO of Satipharm7.4yrsno datano data
5.6yrs
Average Tenure

Experienced Management: DHB's management team is seasoned and experienced (5.6 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Frank Holler
Independent Executive Chairman7.1yrsCA$120.00k3.43%
CA$ 375.0k
Gord Davey
President5yrsCA$590.16k4.52%
CA$ 494.1k
Jason Bednar
Independent Director8.5yrsCA$60.00k2.25%
CA$ 245.7k
David Hyde
Member of the Advisory Board7.1yrsno datano data
Andrew Bayfield
Independent Director5.6yrsCA$60.00k12.88%
CA$ 1.4m
7.1yrs
Average Tenure

Experienced Board: DHB's board of directors are considered experienced (7.1 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/05 06:00
End of Day Share Price 2025/10/03 00:00
Earnings2025/03/31
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Delivra Health Brands Inc. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Siddharth RajeevFundamental Research Corp.
Neal GilmerHaywood Securities Inc.
Greg McLeishResearch Capital Corporation